Search Results
May 21, 2026, 16:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Byrna Technologies Inc. - BYRN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Byrna Technologies Inc. ("Byrna Technologies" or the "Company") (NASDAQ: BYRN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
May 14, 2026, 20:15 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Byrna Technologies Inc. - BYRN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Byrna Technologies Inc. ("Byrna Technologies" or the "Company") (NASDAQ: BYRN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
May 07, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Byrna Technologies Inc. - BYRN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Byrna Technologies Inc. ("Byrna Technologies" or the "Company") (NASDAQ: BYRN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
May 05, 2026, 03:07 ET Hot off the Press: Recent Publications from Improved Pharma and Varda Space Industries Collaboration
field's understanding of polymorphic landscapes in drug development," said Varda Space Industries Chief Science Officer Adrian Radocea.Dr. Stephen Byrn, CSO of Improved Pharma, commented on the importance of these publications. "Through our ongoing research efforts with Varda, we will continue to advance
More news about: Improved Pharma
Apr 30, 2026, 21:42 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Byrna Technologies Inc. - BYRN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Byrna Technologies Inc. ("Byrna Technologies" or the "Company") (NASDAQ: BYRN). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Apr 21, 2026, 02:54 ET Improved Pharma Scientists to Present at Spring Pharmaceutical Synchrotron-XRPD Workshop May 6-8 in Basel, Switzerland
expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.For more information about Improved Pharma's services, please
More news about: Improved Pharma
Feb 11, 2026, 20:25 ET Improved Pharma Expands Pharmaceutical Development Services with New Automated Dissolution Capabilities
solid-state form, formulation design, and manufacturing processes into a single, regulator-accepted measurement," said Steve Byrn, Chief Scientific Officer of Improved Pharma." By upgrading our capabilities, we can offer our clients a deeper understanding of the factors influencing
More news about: Improved Pharma
Feb 09, 2026, 03:01 ET Improved Pharma Announces Enhanced X-Ray Diffraction and Interpretation Services to Strengthen Market Authorization Applications and Patents
that are often mislabeled by standard laboratory methods.The expanded service is led by a team of world-renowned experts, including Dr. Stephen Byrn and staff crystallographer Dr. Jared Smit. By combining high-performance in-house
More news about: Improved Pharma
Jan 27, 2026, 03:00 ET Publication of Crystal Structure of Ritonavir Form IV and Thermodynamic Relationships between Ritonavir Polymorphs
expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.For more information about Improved Pharma's services, please visit
More news about: Improved Pharma
Jan 07, 2026, 03:38 ET New Edition of Seminal Text "Solid-State Materials in Pharmaceutical Chemistry" Released by Industry Leaders
Chemistry: Properties, Characterization, and Applications, published by John Wiley & Sons. Co-authored by distinguished experts Stephen R. Byrn, George Zografi, and Xiaoming (Sean) Chen, this comprehensive volume serves as an essential resource for scientists and researchers navigating the complex
More news about: Improved Pharma
Oct 23, 2025, 03:49 ET Improved Pharma exhibiting and presenting at AAPS 2025 PHARMSCI 360
Industries (#3563). We are conveniently located on the main aisle of the exhibition floor in between the 360 stage and Poster Forum 7. Stephen Byrn, Pam Smith, Susan-Bogdanowich-Knipp, Ruba Alajlouni and Lauren Smith will represent Improved Pharma. Please stop by the booth to discuss your R&D
More news about: Improved Pharma